These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16948499)

  • 21. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
    Kanno S; Hirano S; Kayama F
    Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
    Kawaida R; Ohtsuka T; Okutsu J; Takahashi T; Kadono Y; Oda H; Hikita A; Nakamura K; Tanaka S; Furukawa H
    J Exp Med; 2003 Apr; 197(8):1029-35. PubMed ID: 12707301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
    Huber DM; Bendixen AC; Pathrose P; Srivastava S; Dienger KM; Shevde NK; Pike JW
    Endocrinology; 2001 Sep; 142(9):3800-8. PubMed ID: 11517156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES.
    Kim MS; Magno CL; Day CJ; Morrison NA
    J Cell Biochem; 2006 Feb; 97(3):512-8. PubMed ID: 16211583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis.
    Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF
    J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U; Patel K; Rosol TJ; Ostrowski MC
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis.
    Kimachi K; Kajiya H; Nakayama S; Ikebe T; Okabe K
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):297-308. PubMed ID: 21225243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Osteoclast differentiation of Raw264.7 cells expressing enhanced green fluorescent protein in vitro].
    Pei Y; Lyu C; Liu H
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Apr; 50(4):235-9. PubMed ID: 26081961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation.
    Kim MS; Day CJ; Morrison NA
    J Biol Chem; 2005 Apr; 280(16):16163-9. PubMed ID: 15722361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation.
    Mandelin J; Liljeström M; Li TF; Ainola M; Hukkanen M; Salo J; Santavirta S; Konttinen YT
    J Biomed Mater Res B Appl Biomater; 2005 Jul; 74(1):582-8. PubMed ID: 15768436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
    Hiruma Y; Hirai T; Tsuda E
    Biochem Biophys Res Commun; 2011 Jun; 409(3):424-9. PubMed ID: 21586272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
    Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW
    Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts.
    Takeshita S; Kaji K; Kudo A
    J Bone Miner Res; 2000 Aug; 15(8):1477-88. PubMed ID: 10934646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells.
    Suzuki N; Yoshimura Y; Deyama Y; Suzuki K; Kitagawa Y
    Int J Mol Med; 2008 Mar; 21(3):291-6. PubMed ID: 18288375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced osteoclast differentiation in an LXRβ-dependent mechanism.
    Remen KM; Henning P; Lerner UH; Gustafsson JÅ; Andersson G
    J Biol Chem; 2011 Sep; 286(38):33084-94. PubMed ID: 21784849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.